Annual report
9341.TEDINET S100R2ZE
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 117
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥3.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥804m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥686m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥629m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥688m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥5.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥2.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥777m | at 2021-03-31d | Cons. | Net assets |
| Cash and deposits | ¥3.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥624m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥113m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥179m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥68m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥60m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥75m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥76.61 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.96 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.88 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.07 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥229.47 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥91.9 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥48.67 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 74.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 45.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 60.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 138.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 294 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 242 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 185 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥6.4bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥4.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥774m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥62m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥71m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.7bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥666m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥605m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥87m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥40m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.3bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥1.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥857m | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥599m | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.4bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥738m | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥133m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥45m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.8bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥75.52 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.72 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.35 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11,085.03 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5,060.45 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥72.03 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥225.51 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥88.65 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥46.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥16,824.21 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,739.17 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 74.8% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 46.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 61.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 139.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 98.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 157.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,598,100 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 80,900 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,890 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,890 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,890 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 269 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 215 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 159 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 145 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 129 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 36 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥532m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥532m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥131m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥160m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥16m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥4.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.1bn |
| Medical Platform Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥48m |
| Medical Platform Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥24m |
| Medical Platform Businessreportable segment | employees | at 2023-03-31 | 168 pure |
| Medical Platform Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Medical Platform Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Medical Platform Businessreportable segment | segment assets | at 2023-03-31 | ¥828m |
| Medical Platform Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Smart Clinic Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥27m |
| Smart Clinic Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥11m |
| Smart Clinic Businessreportable segment | employees | at 2023-03-31 | 50 pure |
| Smart Clinic Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Smart Clinic Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Smart Clinic Businessreportable segment | segment assets | at 2023-03-31 | ¥426m |
| Smart Clinic Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥416m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥75m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥34m |
| —segment total | employees | at 2023-03-31 | 218 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| —segment total | segment assets | at 2023-03-31 | ¥1.3bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥88m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥39m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥11m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥653m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥653m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥124m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥231m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥41m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥12m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥924m |
| Medical Platform Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥49m |
| Medical Platform Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥15m |
| Medical Platform Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Medical Platform Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Medical Platform Businessreportable segment | segment assets | at 2022-03-31 | ¥560m |
| Medical Platform Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Smart Clinic Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥21m |
| Smart Clinic Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥7m |
| Smart Clinic Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Smart Clinic Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Smart Clinic Businessreportable segment | segment assets | at 2022-03-31 | ¥285m |
| Smart Clinic Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥298m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥71m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥22m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.1bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.1bn |
| —segment total | segment assets | at 2022-03-31 | ¥845m |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥25m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥969m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥2.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 17 pure |
| Medical Platform Businessreportable segment | employees | at 2023-03-31 | 164 pure |
| Smart Clinic Businessreportable segment | employees | at 2023-03-31 | 48 pure |
| —segment total | employees | at 2023-03-31 | 212 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,308
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sales of shares of subsidiaries and associates (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary disposed of by sales of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies na financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding assets and liabilities incurred from transactions with affiliated entities (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding transactions with affiliated entities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of securities (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |